Monoclonal Antibody Therapeutics Market - Global Industry Analysis

Monoclonal Antibody Therapeutics Market by Application (Cancer, Autoimmune Diseases, Infection, Hematological Diseases, and Others), By Source and By End Users: Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2023

Published Date: 09-Apr-2018 Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-2752 Status : Published

Global monoclonal antibody therapeutics market expected to generate revenue of around USD 218.97 billion by the end of 2023, growing at a CAGR of around 12.5% between 2017 and 2023. Monoclonal antibody therapeutics is a type of immunotherapy in which monoclonal antibodies are used so that they can bind monospecifically to specific cells and proteins.

Description

The report covers forecast and analysis for the monoclonal antibody therapeutics market on a global and regional level. The study provides historic data of 2015 to 2017 along with a forecast from 2018 to 2023 based on revenue (USD Billion). The study includes drivers and restraints for the monoclonal antibody therapeutics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the monoclonal antibody therapeutics market on a global level.

In order to give the users of this report a comprehensive view on the monoclonal antibody therapeutics market, we have included a competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, product and regional expansion of major participants involved in the market. 

Global Monoclonal Antibody Therapeutics Market

The study provides a decisive view on the monoclonal antibody therapeutics market by segmenting the market based on application, source, end user and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2023. Based on application, the market is segmented into cancer, autoimmune diseases, infection, hematological diseases, and others. By source, the market is segmented into human, humanized, chimeric and others. Based on end users, the market is segmented into hospitals, private clinics and research institutes. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and Middle East & Africa with its further bifurcation into major countries including the U.S., UK, Germany, France, China, Japan, India, Brazil, etc. This segmentation includes demand for monoclonal antibody therapeutics market based on all segments in all the regions and countries.

The report also includes detailed profiles of end players such as Pfizer Inc., Bayer AG, Sanofi, Merck & Co., Inc., GlaxoSmithKline Plc., F. Hoffmann-La Roche Ltd., Novartis AG, and AbbVie Inc. 

This report segments the global monoclonal antibody therapeutics market as follows:

Global Monoclonal Antibody Therapeutics Market: Application Segment Analysis

  • Cancer
  • Autoimmune Diseases
  • Infection
  • Hematological Diseases
  • Others

Global Monoclonal Antibody Therapeutics Market: Source Segment Analysis

  • Human
  • Humanized
  • Chimeric
  • Others

Global Monoclonal Antibody Therapeutics Market: End User Segment Analysis

  • Hospitals
  • Private Clinics
  • Research Institute

Global Monoclonal Antibody Therapeutics Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Monoclonal Antibody Therapeutics Market, 2015 - 2023 (USD Billion)
    • 2.2. Global Monoclonal Antibody Therapeutics Market: Snapshot
  •  
  • Chapter 3. Monoclonal Antibody Therapeutics Market- Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Global Monoclonal Antibody Therapeutics Market Drivers: Impact Analysis
      • 3.2.2. Growing Monoclonal Antibody Therapeutics Consumption in Developing Countries
      • 3.2.3. Changing Consumption Habits of Monoclonal Antibody Therapeutics
    • 3.3. Market Restraints
      • 3.3.1. Global Monoclonal Antibody Therapeutics Market Restraints: Impact Analysis
      • 3.3.2. High Taxation in Monoclonal Antibody Therapeutics Business and Trade
    • 3.4. Opportunities
      • 3.4.1. Innovative Products with Flavored Monoclonal Antibody Therapeutics
    • 3.5. Porter's Five Forces Analysis
      • 3.5.1. Bargaining Power of Suppliers
      • 3.5.2. Bargaining Power of Buyers
      • 3.5.3. Threat from New Entrants
      • 3.5.4. Threat from New Substitutes
      • 3.5.5. Degree of Competition
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market Attractiveness Analysis, by Application Segment
      • 3.6.2. Market Attractiveness Analysis, by Source Segment
      • 3.6.3. Market Attractiveness Analysis, by End User Segment
      • 3.6.4. Market Attractiveness Analysis, by Regional Segment
  •  
  • Chapter 4. Global Monoclonal Antibody Therapeutics Market- Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Monoclonal Antibody Therapeutics Market: Company Market Share, 2017
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
      • 4.2.4. Research and Development and Regional Expansion
    • 4.3. Price Trend Analysis
  •  
  • Chapter 5. Global Monoclonal Antibody Therapeutics Market- Application Segment Analysis
    • 5.1. Global Monoclonal Antibody Therapeutics Market: Application Overview
      • 5.1.1. Global Monoclonal Antibody Therapeutics Market Revenue Share, by Application, 2017 and 2023
    • 5.2. Cancer
      • 5.2.1. Global Monoclonal Antibody Therapeutics Market for Cancer, 2015 - 2023 (USD Billion)
    • 5.3. Autoimmune Diseases
      • 5.3.1. Global Monoclonal Antibody Therapeutics Market for Autoimmune Diseases, 2015 - 2023 (USD Billion)
    • 5.4. Infection
      • 5.4.1. Global Monoclonal Antibody Therapeutics Market for Infection, 2015 - 2023 (USD Billion)
    • 5.5. Hematological Diseases
      • 5.5.1. Global Monoclonal Antibody Therapeutics Market for Hematological Diseases, 2015 - 2023 (USD Billion)
    • 5.6. Others
      • 5.6.1. Global Monoclonal Antibody Therapeutics Market for Others, 2015 - 2023 (USD Billion)
  •  
  • Chapter 6. Global Monoclonal Antibody Therapeutics Market- Source Segment Analysis
    • 6.1. Global Monoclonal Antibody Therapeutics Market: Source Overview
      • 6.1.1. Global Monoclonal Antibody Therapeutics Market Revenue Share, by Source, 2017 and 2023
    • 6.2. Human
      • 6.2.1. Global Monoclonal Antibody Therapeutics Market for Human, 2015 - 2023 (USD Billion)
    • 6.3. Humanized
      • 6.3.1. Global Monoclonal Antibody Therapeutics Market for Humanized, 2015 - 2023 (USD Billion)
    • 6.4. Chimeric
      • 6.4.1. Global Monoclonal Antibody Therapeutics Market for Chimeric, 2015 - 2023 (USD Billion)
    • 6.5. Others
      • 6.5.1. Global Monoclonal Antibody Therapeutics Market for Others, 2015 - 2023 (USD Billion)
  •  
  • Chapter 7. Global Monoclonal Antibody Therapeutics Market- End User Segment Analysis
    • 7.1. Global Monoclonal Antibody Therapeutics Market: End User Overview
      • 7.1.1. Global Monoclonal Antibody Therapeutics Market Revenue Share, by End User, 2017 and 2023
    • 7.2. Hospitals
      • 7.2.1. Global Monoclonal Antibody Therapeutics Market for Hospitals, 2015 - 2023 (USD Billion)
    • 7.3. Private Clinics
      • 7.3.1. Global Monoclonal Antibody Therapeutics Market for Private Clinics, 2015 - 2023 (USD Billion)
    • 7.4. Research Institutes
      • 7.4.1. Global Monoclonal Antibody Therapeutics Market for Research Institutes, 2015 - 2023 (USD Billion)
  •  
  • Chapter 8. Global Monoclonal Antibody Therapeutics Market- Regional Segment Analysis
    • 8.1. Global Monoclonal Antibody Therapeutics Market: Regional Overview
      • 8.1.1. Global Monoclonal Antibody Therapeutics Market Revenue Share, by Region, 2017 And 2023
    • 8.2. North America
      • 8.2.1. North America Monoclonal Antibody Therapeutics Market, 2015 - 2023 (USD Billion)
      • 8.2.2. North America Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
      • 8.2.3. North America Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
      • 8.2.4. North America Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
      • 8.2.5. U.S.
        • 8.2.5.1. U.S. Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
        • 8.2.5.2. U.S. Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
        • 8.2.5.3. U.S. Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
      • 8.2.6. Rest of North America
        • 8.2.6.1. Rest of North America Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
        • 8.2.6.2. Rest of North America Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
        • 8.2.6.3. Rest of North America Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
    • 8.3. Europe
      • 8.3.1. Europe Monoclonal Antibody Therapeutics Market, 2015 - 2023 (USD Billion)
      • 8.3.2. Europe Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
      • 8.3.3. Europe Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
      • 8.3.4. Europe Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
      • 8.3.5. UK
        • 8.3.5.1. UK Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
        • 8.3.5.2. UK Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
        • 8.3.5.3. UK Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
      • 8.3.6. Germany
        • 8.3.6.1. Germany Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
        • 8.3.6.2. Germany Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
        • 8.3.6.3. Germany Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
      • 8.3.7. France
        • 8.3.7.1. France Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
        • 8.3.7.2. France Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
        • 8.3.7.3. France Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
      • 8.3.8. Rest of Europe
        • 8.3.8.1. Rest of Europe Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
        • 8.3.8.2. Rest of Europe Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
        • 8.3.8.3. Rest of Europe Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Monoclonal Antibody Therapeutics Market, 2015 - 2023 (USD Billion)
      • 8.4.2. Asia Pacific Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
      • 8.4.3. Asia Pacific Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
      • 8.4.4. Asia Pacific Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
      • 8.4.5. China
        • 8.4.5.1. China Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
        • 8.4.5.2. China Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
        • 8.4.5.3. China Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
      • 8.4.6. Japan
        • 8.4.6.1. Japan Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
        • 8.4.6.2. Japan Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
        • 8.4.6.3. Japan Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
      • 8.4.7. India
        • 8.4.7.1. India Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
        • 8.4.7.2. India Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
        • 8.4.7.3. India Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
      • 8.4.8. Rest of Asia Pacific
        • 8.4.8.1. Rest of Asia Pacific Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
        • 8.4.8.2. Rest of Asia Pacific Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
        • 8.4.8.3. Rest of Asia Pacific Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
    • 8.5. Latin America
      • 8.5.1. Latin America Monoclonal Antibody Therapeutics Market, 2015 - 2023 (USD Billion)
      • 8.5.2. Latin America Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
      • 8.5.3. Latin America Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
      • 8.5.4. Rest of North America Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
      • 8.5.5. Brazil
        • 8.5.5.1. Brazil Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
        • 8.5.5.2. Brazil Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
        • 8.5.5.3. Brazil Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
      • 8.5.6. Rest of Latin America
        • 8.5.6.1. Rest of Latin America Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
        • 8.5.6.2. Rest of Latin America Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
        • 8.5.6.3. Rest of Latin America Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
    • 8.6. Middle East and Africa
      • 8.6.1. Middle East and Africa Monoclonal Antibody Therapeutics Market, 2015 - 2023 (USD Billion)
      • 8.6.2. Middle East and Africa Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
      • 8.6.3. Middle East and Africa Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
      • 8.6.4. Middle East and Africa Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
  •  
  • Chapter 9. Company Profile
    • 9.1. Pfizer Inc.
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product Portfolio
      • 9.1.4. Business Strategy
      • 9.1.5. Recent Developments
    • 9.2. Bayer AG
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product Portfolio
      • 9.2.4. Business Strategy
      • 9.2.5. Recent Developments
    • 9.3. Sanofi
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product Portfolio
      • 9.3.4. Business Strategy
      • 9.3.5. Recent Developments
    • 9.4. Merck & Co., Inc.
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product Portfolio
      • 9.4.4. Business Strategy
      • 9.4.5. Recent Developments
    • 9.5. GlaxoSmithKline Plc.
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product Portfolio
      • 9.5.4. Business Strategy
      • 9.5.5. Recent Developments
    • 9.6. F. Hoffmann-La Roche Ltd.
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product Portfolio
      • 9.6.4. Business Strategy
      • 9.6.5. Recent Developments
    • 9.7. Novartis AG
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product Portfolio
      • 9.7.4. Business Strategy
      • 9.7.5. Recent Developments
    • 9.8. Holdings AbbVie Inc.
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product Portfolio
      • 9.8.4. Business Strategy
      • 9.8.5. Recent Developments

Table Of Figures

List of Figures 

1. Market Research Process
2. Market Research Methodology
3. Global Monoclonal Antibody Therapeutics Market Revenue, 2015 – 2023 (USD Billion) 
4. Porter’s Five Forces Analysis
5. Monoclonal Antibody Therapeutics Market Attractiveness Analysis, by Application Segment
6. Monoclonal Antibody Therapeutics Market Attractiveness Analysis, by Source Segment
7. Monoclonal Antibody Therapeutics Market Attractiveness Analysis, by End-User Segment
8. Monoclonal Antibody Therapeutics Market: Market Attractiveness Analysis, by Regional Segment
9. Company Market Share Analysis, 2017 
10. Global Monoclonal Antibody Therapeutics Market Revenue Share by Application, 2017 And 2023
11. Global Monoclonal Antibody Therapeutics Market for Cancer, 2015 – 2023 (USD Billion)
12. Global Monoclonal Antibody Therapeutics Market for Autoimmune Diseases, 2015 – 2023 (USD Billion)
13. Global Monoclonal Antibody Therapeutics Market for Infection, 2015 – 2023 (USD Billion)
14. Global Monoclonal Antibody Therapeutics Market for Hematological Diseases, 2015 – 2023 (USD Billion)
15. Global Monoclonal Antibody Therapeutics Market for Others, 2015 – 2023 (USD Billion)
16. Global Monoclonal Antibody Therapeutics Market Revenue Share by Source, 2017 And 2023
17. Global Monoclonal Antibody Therapeutics Market for Human, 2015 – 2023 (USD Billion)
18. Global Monoclonal Antibody Therapeutics Market for Humanized, 2015 – 2023 (USD Billion)
19. Global Monoclonal Antibody Therapeutics Market for Chimeric, 2015 – 2023 (USD Billion) 
20. Global Monoclonal Antibody Therapeutics Market for Others, 2015 – 2023 (USD Billion)
21. Global Monoclonal Antibody Therapeutics Market Revenue Share by End User, 2017 And 2023
22. Global Monoclonal Antibody Therapeutics Market for Hospitals, 2015 – 2023 (USD Billion)
23. Global Monoclonal Antibody Therapeutics Market for Private Clinics, 2015 – 2023 (USD Billion)
24. Global Monoclonal Antibody Therapeutics Market for Research Institutes, 2015 – 2023 (USD Billion)
25. North America Monoclonal Antibody Therapeutics Market, 2015-2023 (USD Billion)
26. Europe Monoclonal Antibody Therapeutics Market, 2015-2023 (USD Billion)
27. Asia Pacific Monoclonal Antibody Therapeutics Market, 2015-2023 (USD Billion)
28. Latin America Monoclonal Antibody Therapeutics Market, 2015-2023 (USD Billion)
29. Middle East and Africa Monoclonal Antibody Therapeutics Market, 2015-2023 (USD Billion)


Table Of Tables

List of Tables

1. Monoclonal Antibody Therapeutics Market: Market Snapshot

2. Drivers of Global Monoclonal Antibody Therapeutics Market: Impact Analysis 
3. Restraints of Global Monoclonal Antibody Therapeutics Market: Impact Analysis  
4. North America Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 – 2023 (USD Billion)
5. North America Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 – 2023 (USD Billion)
6. North America Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 – 2023 (USD Billion)
7. U.S. Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 – 2023 (USD Billion)
8. U.S. Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 – 2023 (USD Billion)
9. U.S. Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 – 2023 (USD Billion)
10. Rest of North America Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 – 2023 (USD Billion)
11. Rest of North America Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 – 2023 (USD Billion)
12. Rest of North America Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 – 2023 (USD Billion)
13. Europe Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 – 2023 (USD Billion)
14. Europe Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 – 2023 (USD Billion)
15. Europe Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 – 2023 (USD Billion)
16. UK Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 – 2023 (USD Billion)
17. UK Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 – 2023 (USD Billion)
18. UK Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 – 2023 (USD Billion)
19. Germany Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 – 2023 (USD Billion)
20. Germany Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 – 2023 (USD Billion)
21. Germany Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 – 2023 (USD Billion)
22. France Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 – 2023 (USD Billion)
23. France Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 – 2023 (USD Billion)
24. France Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 – 2023 (USD Billion)
25. Rest of Europe Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 – 2023 (USD Billion)
26. Rest of Europe Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 – 2023 (USD Billion)
27. Rest of Europe Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 – 2023 (USD Billion)
28. Asia Pacific Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 – 2023 (USD Billion)
29. Asia Pacific Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 – 2023 (USD Billion)
30. Asia Pacific Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 – 2023 (USD Billion)
31. China Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 – 2023 (USD Billion)
32. China Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 – 2023 (USD Billion)
33. China Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 – 2023 (USD Billion)
34. Japan Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 – 2023 (USD Billion)
35. Japan Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 – 2023 (USD Billion)
36. Japan Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 – 2023 (USD Billion)
37. India Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 – 2023 (USD Billion)
38. India Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 – 2023 (USD Billion)
39. India Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 – 2023 (USD Billion)
40. Rest of Asia Pacific Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 – 2023 (USD Billion)
41. Rest of Asia Pacific Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 – 2023 (USD Billion)
42. Rest of Asia Pacific Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 – 2023 (USD Billion)
43. Latin America Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 – 2023 (USD Billion)
44. Latin America Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 – 2023 (USD Billion)
45. Latin America Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 – 2023 (USD Billion)
46. Brazil Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 – 2023 (USD Billion)
47. Brazil Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 – 2023 (USD Billion)
48. Brazil Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 – 2023 (USD Billion)
49. Rest of Latin America Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 – 2023 (USD Billion)
50. Rest of Latin America Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 – 2023 (USD Billion)
51. Rest of Latin America Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 – 2023 (USD Billion)
52. Middle East and Africa Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 – 2023 (USD Billion)
53. Middle East and Africa Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 – 2023 (USD Billion)
54. The Middle East and Africa Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 – 2023 (USD Billion)

Methodology

Free Analysis

Monoclonal antibody therapeutics is a type of therapy in which monoclonal antibodies are used to target a specific cell, which can cause various diseases. Monoclonal antibodies are the once which have identical structures as they are produced from one type of immune cell. An antibody is a protein that binds to a specific protein called antigen. They target various receptors on the cell surface and modulate their vital functions and cause cell death through various mechanism. Antibodies have two main functions namely recognize and bind to the target cell or antigen to induce immune response against the antigen. When a monoclonal antibody binds to the specific target cell it induces the immune response against the cell, which helps to decrease the effect of the disease in humans.

Researchers have designed various monoclonal antibodies which are specific in various diseases including cancer. As there is rapid increase in the number of patients suffering from cancer, demand for global monoclonal antibody therapeutics market is expected to grow. Growing chronic diseases and increasing health concerns also act as a driver for the growth of this market. Technological advancements in the field of healthcare are also fueling the growth of the market. Use of monoclonal antibody products is approved in regions like Europe and U.S.; therefore there is increase in demand for monoclonal antibody therapeutics. However, due to introduction of biosimilars the growth of global monoclonal antibody therapeutics market is hindered. High cost of monoclonal antibody therapeutics is also expected to affect the growth of the market in the forecast period. Time-consuming procedures for production of monoclonal antibodies and strict approval procedures are also hampering the growth of the global monoclonal antibody therapeutics market.

Global Monoclonal Antibody Therapeutics Market

Based on application, the market is segmented into cancer, autoimmune diseases, infection, hematological diseases and others. Autoimmune diseases segment is expected to dominate the global monoclonal antibody therapeutics market during in the forecast period. Based on source, the market is segmented into human, humanized, chimeric, and others. The human monoclonal antibody segment is expected to dominate the global monoclonal antibody therapeutics market.

Based on end user, the market is segmented into hospitals, private clinics and research institute. Research institute segment is anticipated to dominate the global monoclonal antibody therapeutics market in the future. North America is projected to continue its supremacy, in global monoclonal antibody therapeutics market, which will be followed by Europe, in the forthcoming years. The growth of this regional market is due to the increasing technological advancements in the region.

Some of the key players in the global monoclonal antibody therapeutics market are Pfizer Inc., Bayer AG, Sanofi, Merck & Co., Inc., GlaxoSmithKline Plc., F. Hoffmann-La Roche Ltd., Novartis AG, and AbbVie Inc.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed